EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of miR-148a-3p and miR-106a-5p as Biomarkers for Prostate Cancer: Pilot Study

Roxana Andra Coman iD, Vlad Horia Schitcu iD, Liviuta Budisan iD, Lajos Raduly iD, Cornelia Braicu iD, Bogdan Petrut iD, Ioan Coman, Ioana Berindan-Neagoe iD, Nadim Al Hajjar

Genes · 04.05.2024 · 15 (5) · 584

DOI: 10.3390/genes15050584 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 04.05.2024. Verfasst von Roxana Andra Coman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: MicroRNAs, Prostatic Neoplasms, Biomarkers, Tumor, Prostatic Hyperplasia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iuliu Hațieganu University of Medicine and Pharmacy of Cluj-Napoca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MicroRNAs (miRNAs) are a class of small non-coding RNAs that may function as tumor suppressors or oncogenes. Alteration of their expression levels has been linked to a range of human malignancies, including cancer. The objective of this investigation is to assess the relative expression levels of certain miRNAs to distinguish between prostate cancer (PCa) from benign prostatic hyperplasia (BPH). Blood plasma was collected from 66 patients diagnosed with BPH and 58 patients with PCa. Real-time PCR technology was used to evaluate the relative expression among the two groups for miR-106a-5p and miR-148a-3p. The significant downregulation of both miRNAs in plasma from PCa versus BPH patients suggests their potential utility as diagnostic biomarkers for distinguishing between these conditions. The concurrent utilization of these two miRNAs slightly enhanced the sensitivity for discrimination among the two analyzed groups, as shown in ROC curve analysis. Further validation of these miRNAs in larger patient cohorts and across different stages of PCa may strengthen their candidacy as clinically relevant biomarkers for diagnosis and prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsProstatic NeoplasmsBiomarkers, TumorProstatic HyperplasiaHumansMaleAgedMiddle AgedPilot ProjectsGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

miR-106a-5pmiR-148a-3pmicroRNAsprostate cancer

Substanzen

MicroRNAsMIRN148 microRNA, humanBiomarkers, TumorMIRN106 microRNA, human

Autor:innen und Institutionen

  • Department of Urology, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Department of Urology, "Prof Dr. Ion Chiricuta" Oncology Institute, 400015 Cluj-Napoca, Romania.
  • Research Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania.
  • Department of Surgery, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Department of Surgery, Regional Institute of Gastroenterology and Hepatology "Octavian Fodor", 400394 Cluj-Napoca, Romania.

ORCID-Profile: Roxana Andra Coman, Vlad Horia Schitcu, Liviuta Budisan, Lajos Raduly, Cornelia Braicu, Bogdan Petrut, Ioana Berindan-Neagoe

Förderung

  • Iuliu Hațieganu University of Medicine and Pharmacy of Cluj-Napoca

Zitieren

APA

Coman, R. A., Schitcu, V. H., Budisan, L., Raduly, L., Braicu, C., Petrut, B., Coman, I., Berindan-Neagoe, I., & Al Hajjar, N. (2024). Evaluation of miR-148a-3p and miR-106a-5p as Biomarkers for Prostate Cancer: Pilot Study. Genes, 15(5), 584. https://doi.org/10.3390/genes15050584

Vancouver

Coman RA, Schitcu VH, Budisan L, Raduly L, Braicu C, Petrut B, et al. Evaluation of miR-148a-3p and miR-106a-5p as Biomarkers for Prostate Cancer: Pilot Study. Genes. 2024;15(5):584. doi:10.3390/genes15050584

BibTeX
@article{Coman2024,
  author = {Coman, Roxana Andra and Schitcu, Vlad Horia and Budisan, Liviuta and Raduly, Lajos and Braicu, Cornelia and Petrut, Bogdan and Coman, Ioan and Berindan-Neagoe, Ioana and Al Hajjar, Nadim},
  title = {Evaluation of miR-148a-3p and miR-106a-5p as Biomarkers for Prostate Cancer: Pilot Study},
  journal = {Genes},
  year = {2024},
  volume = {15},
  number = {5},
  pages = {584},
  doi = {10.3390/genes15050584}
}
Kostenlos starten →